{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T14:23:29Z","timestamp":1768746209563,"version":"3.49.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.phrs.2016.11.030","type":"journal-article","created":{"date-parts":[[2016,11,24]],"date-time":"2016-11-24T23:20:08Z","timestamp":1480029608000},"page":"129-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["sec -Butylpropylacetamide (SPD), a new amide derivative of valproic acid for the treatment of neuropathic and inflammatory pain"],"prefix":"10.1016","volume":"117","author":[{"given":"Dan","family":"Kaufmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"West","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misty D.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"Yagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meir","family":"Bialer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marshall","family":"Devor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Steve","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.C.","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.phrs.2016.11.030_bib0005","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1213\/01.ane.0000268145.52345.55","article-title":"Pain management: a fundamental human right","volume":"105","author":"Brennan","year":"2007","journal-title":"Anesth. Analg."},{"issue":"Suppl","key":"10.1016\/j.phrs.2016.11.030_bib0010","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/nn942","article-title":"Can we conquer pain?","volume":"5","author":"Scholz","year":"2002","journal-title":"Nat. Neurosci."},{"issue":"Suppl. (1)","key":"10.1016\/j.phrs.2016.11.030_bib0015","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2165\/11630030-000000000-00000","article-title":"Heterogeneity of chronic pain","volume":"32","author":"Vellucci","year":"2012","journal-title":"Clin. Drug Investig."},{"issue":"3","key":"10.1016\/j.phrs.2016.11.030_bib0020","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jbspin.2011.10.008","article-title":"Pain and immunity","volume":"79","author":"Guillot","year":"2012","journal-title":"Joint Bone Spine"},{"issue":"3","key":"10.1016\/j.phrs.2016.11.030_bib0025","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s11302-012-9306-7","article-title":"P2\u00d74 purinoceptor signaling in chronic pain","volume":"8","author":"Trang","year":"2012","journal-title":"Purinergic Signal."},{"issue":"2","key":"10.1016\/j.phrs.2016.11.030_bib0030","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.expneurol.2011.12.021","article-title":"Immune responses of microglia in the spinal cord: contribution to pain states","volume":"234","author":"Schomberg","year":"2012","journal-title":"Exp. Neurol."},{"issue":"7","key":"10.1016\/j.phrs.2016.11.030_bib0035","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/nrn1700","article-title":"Role of the immune system in chronic pain","volume":"6","author":"Marchand","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"issue":"11","key":"10.1016\/j.phrs.2016.11.030_bib0040","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1038\/nm.2234","article-title":"Interactions between the immune and nervous systems in pain","volume":"16","author":"Ren","year":"2010","journal-title":"Nat. Med."},{"issue":"1\u20132","key":"10.1016\/j.phrs.2016.11.030_bib0045","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jneuroim.2010.08.013","article-title":"The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines","volume":"229","author":"Austin","year":"2010","journal-title":"J. Neuroimmunol."},{"issue":"11","key":"10.1016\/j.phrs.2016.11.030_bib0050","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1038\/nn1992","article-title":"The neuropathic pain triad: neurons, immune cells and glia","volume":"10","author":"Scholz","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.phrs.2016.11.030_bib0055","series-title":"Wall and Melzack\u2019s Textbook of Pain","first-page":"861","article-title":"Neuropathic pain: pathophysiological response of nerves to injury","author":"Devor","year":"2013"},{"issue":"5","key":"10.1016\/j.phrs.2016.11.030_bib0060","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1097\/ACO.0b013e32830edbdf","article-title":"Neuron-glia crosstalk gets serious: role in pain hypersensitivity","volume":"21","author":"Ren","year":"2008","journal-title":"Curr. Opin. Anaesthesiol."},{"issue":"2 Suppl. Pain","key":"10.1016\/j.phrs.2016.11.030_bib0065","first-page":"3","article-title":"Adjuvant analgesics for the treatment of neuropathic pain: evaluating efficacy and safety profiles","volume":"56","author":"Forde","year":"2007","journal-title":"J. Fam. Pract."},{"issue":"11","key":"10.1016\/j.phrs.2016.11.030_bib0070","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1111\/j.1468-1331.2006.01511.x","article-title":"EFNS guidelines on pharmacological treatment of neuropathic pain","volume":"13","author":"Attal","year":"2006","journal-title":"Eur. J. Neurol."},{"issue":"3","key":"10.1016\/j.phrs.2016.11.030_bib0075","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.pain.2007.08.033","article-title":"Pharmacologic management of neuropathic pain: evidence-based recommendations","volume":"132","author":"Dworkin","year":"2007","journal-title":"Pain"},{"issue":"7\u20138","key":"10.1016\/j.phrs.2016.11.030_bib0080","first-page":"425","article-title":"Opioid therapy for chronic noncancer pain: practice guidelines for initiation and maintenance of therapy","volume":"71","author":"Coluzzi","year":"2005","journal-title":"Minerva Anestesiol."},{"issue":"3","key":"10.1016\/j.phrs.2016.11.030_bib0085","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.genhosppsych.2008.12.006","article-title":"Pharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviews","volume":"31","author":"Kroenke","year":"2009","journal-title":"Gen. Hosp. Psychiatry"},{"issue":"1","key":"10.1016\/j.phrs.2016.11.030_bib0090","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1528-1167.2011.03338.x","article-title":"A new derivative of valproic acid amide possesses a broad-spectrum antiseizure profile and unique activity against status epilepticus and organophosphate neuronal damage","volume":"53","author":"White","year":"2012","journal-title":"Epilepsia"},{"issue":"22","key":"10.1016\/j.phrs.2016.11.030_bib0095","doi-asserted-by":"publisher","first-page":"7236","DOI":"10.1021\/jm901229s","article-title":"Synthesis and evaluation of antiallodynic and anticonvulsant activity of novel amide and urea derivatives of valproic acid analogues","volume":"52","author":"Kaufmann","year":"2009","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.phrs.2016.11.030_bib0100","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.mayocp.2015.01.018","article-title":"Neuropathic pain: principles of diagnosis and treatment","volume":"90","author":"Gilron","year":"2015","journal-title":"Mayo Clin. Proc."},{"issue":"Suppl. (7)","key":"10.1016\/j.phrs.2016.11.030_bib0105","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/j.1528-1167.2012.03712.x","article-title":"Why are antiepileptic drugs used for nonepileptic conditions?","volume":"53","author":"Bialer","year":"2012","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.phrs.2016.11.030_bib0110","doi-asserted-by":"publisher","first-page":"94","DOI":"10.4103\/0976-500X.72351","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"1","author":"Kilkenny","year":"2010","journal-title":"J. Pharmacol. Pharmacother."},{"issue":"3","key":"10.1016\/j.phrs.2016.11.030_bib0115","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/0304-3959(92)90041-9","article-title":"An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat","volume":"50","author":"Kim","year":"1992","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.phrs.2016.11.030_bib0120","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/0304-3959(87)90088-1","article-title":"The formalin test in mice: dissociation between inflammatory and non-inflammatory pain","volume":"30","author":"Hunskaar","year":"1987","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.phrs.2016.11.030_bib0125","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0304-3959(90)90073-M","article-title":"The rat paw formalin test: comparison of noxious agents","volume":"40","author":"Wheeler-Aceto","year":"1990","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.phrs.2016.11.030_bib0130","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/0304-3959(92)90003-T","article-title":"The formalin test: an evaluation of the method","volume":"51","author":"Tjolsen","year":"1992","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.phrs.2016.11.030_bib0135","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0304-3959(88)90026-7","article-title":"A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia","volume":"32","author":"Hargreaves","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.phrs.2016.11.030_bib0140","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/srep00380","article-title":"TRPA1 contributes to the acute inflammatory response and mediates carrageenan-induced paw edema in the mouse","volume":"2","author":"Moilanen","year":"2012","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2016.11.030_bib0145","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0022-3565(25)26120-1","article-title":"Pharmacology of 2-amino-indane hydrochloride (Su-8629): a potent non-narcotic analgesic","volume":"133","author":"Witkin","year":"1961","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.phrs.2016.11.030_bib0150","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s11062-007-0031-8","article-title":"Sucrose gap technique: advantages and limitations","volume":"39","author":"Mert","year":"2007","journal-title":"Neurophysiology"},{"issue":"12","key":"10.1016\/j.phrs.2016.11.030_bib0155","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/BF02166189","article-title":"A new method for measuring membrane potentials with external electrodes","volume":"10","author":"Stampfli","year":"1954","journal-title":"Experientia"},{"key":"10.1016\/j.phrs.2016.11.030_bib0160","unstructured":"Tallarida Ronald J., M.R.B., Manual of Pharmacological Calculations with Computer Programs (1987) New York Springer-Verlag."},{"key":"10.1016\/j.phrs.2016.11.030_bib0165","series-title":"Probit Analysis","author":"Finney","year":"1971"},{"issue":"12","key":"10.1016\/j.phrs.2016.11.030_bib0170","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1023\/A:1007669411738","article-title":"Bioanalytical method validation\u2013a revisit with a decade of progress","volume":"17","author":"Shah","year":"2000","journal-title":"Pharm. Res."},{"issue":"8","key":"10.1016\/j.phrs.2016.11.030_bib0175","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.neuropharm.2005.06.008","article-title":"Efficacy of antiepileptic tetramethylcyclopropyl analogues of valproic acid amides in a rat model of neuropathic pain","volume":"49","author":"Winkler","year":"2005","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.phrs.2016.11.030_bib0180","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/sj.bjp.0706310","article-title":"Efficacy of antiepileptic isomers of valproic acid and valpromide in a rat model of neuropathic pain","volume":"146","author":"Winkler","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.11.030_bib0185","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1289\/ehp.8670113","article-title":"Species differences in pharmacokinetics and drug teratogenesis","volume":"70","author":"Nau","year":"1986","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.phrs.2016.11.030_bib0190","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g1799","article-title":"Painful diabetic neuropathy","volume":"348","author":"Peltier","year":"2014","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.phrs.2016.11.030_bib0195","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/sc.2013.146","article-title":"Anticonvulsant medication use for the management of pain following spinal cord injury: systematic review and effectiveness analysis","volume":"52","author":"Guy","year":"2014","journal-title":"Spinal Cord"},{"issue":"3","key":"10.1016\/j.phrs.2016.11.030_bib0200","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/sj.bjp.0706348","article-title":"Inhibitors of fatty acid amide hydrolase reduce carrageenan-induced hind paw inflammation in pentobarbital-treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors","volume":"146","author":"Holt","year":"2005","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2016.11.030_bib0205","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3109\/07853899509031965","article-title":"Visceral pain: mechanisms of peripheral and central sensitization","volume":"27","author":"Cervero","year":"1995","journal-title":"Ann. Med."},{"issue":"4","key":"10.1016\/j.phrs.2016.11.030_bib0210","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.pnpbp.2004.01.015","article-title":"Isobolographic analysis of interaction between cyclooxygenase inhibitors and tramadol in acetic acid-induced writhing in mice","volume":"28","author":"Satyanarayana","year":"2004","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry."},{"issue":"Suppl. (1)","key":"10.1016\/j.phrs.2016.11.030_bib0215","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000268115","article-title":"Visceral versus somatic pain: similarities and differences","volume":"27","author":"Cervero","year":"2009","journal-title":"Dig. Dis."},{"issue":"7","key":"10.1016\/j.phrs.2016.11.030_bib0220","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.neuropharm.2005.01.013","article-title":"Comparison of the effects of anticonvulsant drugs with diverse mechanisms of action in the formalin test in rats","volume":"48","author":"Shannon","year":"2005","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.phrs.2016.11.030_bib0225","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1213\/ane.0b013e318172b993","article-title":"The antinociceptive effects of anticonvulsants in a mouse visceral pain model","volume":"106","author":"Stepanovic-Petrovic","year":"2008","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.phrs.2016.11.030_bib0230","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3109\/03009748809104663","article-title":"Pharmacological criteria for risk-benefit evaluation of NSAIDs","volume":"73","author":"Albengres","year":"1988","journal-title":"Scand. J. Rheumatol. Suppl."},{"issue":"1","key":"10.1016\/j.phrs.2016.11.030_bib0235","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/0014-2999(76)90004-2","article-title":"Quantitative comparison of the analgesic and anti-inflammatory activities of aspirin: phenacetin and acetaminophen in rodents","volume":"37","author":"Vinegar","year":"1976","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2016.11.030_bib0240","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.neuropharm.2006.07.025","article-title":"Dexketoprofen-induced antinociception in animal models of acute pain: synergy with morphine and paracetamol","volume":"52","author":"Miranda","year":"2007","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.phrs.2016.11.030_bib0245","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0022-3565(25)24843-1","article-title":"Structure-activity relationship of lidocaine homologs producing tonic and frequency-dependent impulse blockade in nerve","volume":"237","author":"Bokesch","year":"1986","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.phrs.2016.11.030_bib0250","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0022-3565(25)31457-6","article-title":"The rates of interaction of local anesthetics with sodium channels in nerve","volume":"207","author":"Courtney","year":"1978","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1\u20133","key":"10.1016\/j.phrs.2016.11.030_bib0255","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0014-2999(02)01368-7","article-title":"Comparison of nerve conduction blocks by an opioid and a local anesthetic","volume":"439","author":"Mert","year":"2002","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2016.11.030_bib0260","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.neulet.2004.03.018","article-title":"Changes in electrophysiological properties of regenerating rat peripheral nerves after crush injury","volume":"363","author":"Mert","year":"2004","journal-title":"Neurosci. Lett."},{"issue":"5","key":"10.1016\/j.phrs.2016.11.030_bib0265","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1213\/00000539-198905000-00004","article-title":"The role of length of nerve exposed to local anesthetics in impulse blocking action","volume":"68","author":"Raymond","year":"1989","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.phrs.2016.11.030_bib0270","article-title":"sec-Butylpropylacetamide (SPD) has antimigraine properties","author":"Kaufmann","year":"2015","journal-title":"Cephalalgia"},{"issue":"3","key":"10.1016\/j.phrs.2016.11.030_bib0275","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.pain.2008.10.015","article-title":"Genuine antihyperalgesia by systemic diazepam revealed by experiments in GABAA receptor point-mutated mice","volume":"141","author":"Knabl","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.phrs.2016.11.030_bib0280","article-title":"Species differenfces in pharmacokinetics, drug metabolism and teratogenesis","volume":"1","author":"Nau","year":"1987"},{"issue":"6","key":"10.1016\/j.phrs.2016.11.030_bib0285","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.yebeh.2004.08.021","article-title":"Correlation analysis between anticonvulsant ED50 values of antiepileptic drugs in mice and rats and their therapeutic doses and plasma levels","volume":"5","author":"Bialer","year":"2004","journal-title":"Epilepsy Behav."},{"issue":"3","key":"10.1016\/j.phrs.2016.11.030_bib0290","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/BF00315032","article-title":"Pharmacokinetics of a valpromide isomer: valnoctamide, in healthy subjects","volume":"38","author":"Bialer","year":"1990","journal-title":"Eur. J. Clin. Pharmacol."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816305138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816305138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T21:19:53Z","timestamp":1749763193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661816305138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":58,"alternative-id":["S1043661816305138"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2016.11.030","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"sec-Butylpropylacetamide (SPD), a new amide derivative of valproic acid for the treatment of neuropathic and inflammatory pain","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2016.11.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}